Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, ...

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C ...

A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...

FDA approved zidesamtinib for previously treated ROS1+ locally advanced/metastatic NSCLC, marking GSK’s entry into approved lung cancer therapeutics following acquisition of Nuvalent’s portfolio. ROS1 ...

Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and bispecifics will bring another shift. The shift toward subcutaneous ...

Cardiovascular (cMRI) identified that left bundle branch block (LBBB) does not significantly alter left atrial (LA) strain parameters in patients with ischemic or nonischemic dilated cardiomyopathy ...

Treatment-refractory generalized MG (~11% in a strict Austrian cohort) is associated with frequent exacerbations, rescue therapy needs, escalated immunosuppression, and sustained disability, ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...

Paul Hahn, MD, says access and reimbursement, not innovation, are retina care’s biggest barriers and outlines where the field is headed next. The biggest obstacle to translating retina’s technology ...

A nationwide Optum claims cohort (413,450 PMOS; 2,067,250 controls) showed composite ASCVD incidence 4.52 vs 0.78 per 1000 person-years and an adjusted HR of 4.40. Coronary artery disease, ...

Modeling of 82 brand drugs with ≥$100 million Medicaid spend found net prices exceeded at least one international reference price for more than 90% of products. State-level gains were heterogeneous, ...